Another Innovus product that Damaj highlighted in the interview is APEAZ™, an FDA-compliant, fast-acting arthritis pain relief cream, formulated to target the joints where arthritis resides. APEAZ™ is one of the most intensive over-the-counter ("OTC") topical treatments for arthritis pain relief available today. APEAZ™ is available in regular and extra-strength formulations. The product was designed to relieve acute pain, arthritis pain, athletic injuries, muscle soreness and/or stiffness, muscle and joint pain, simple backache, strains and sprains.In addition, Damaj pointed out that Innovus will use mainly online wholesalers. Robert Verfurth, VP of Sales and Marketing, will lead the sales and marketing efforts of Innovus products to ensure revenues and cash flow. For its prescription products, Innovus plans to partner with companies who already have infrastructure, sales force and distribution. Damaj noted that prior to joining Innovus, he was the CEO of Apricus Biosciences, a company listed under the symbol (Nasdaq:APRI), that grew from a market capitalization of $17 million to more than $100 million during his tenure. He also noted that Innovus is currently preparing to list on NASDAQ. About Innovus Pharma Innovus Pharma, headquartered in La Jolla, CA, is an emerging pharmaceutical company that delivers innovative and uniquely presented and packaged healthcare solutions through both prescription medicines and consumer and health products. The Company intends to grow by developing, in-licensing, acquiring and marketing proprietary respiratory, dermatology, autoimmune and sexual dysfunction pharmaceutical products intended for better patient compliance and results. The Company is building a robust pipeline with a wide range of approved products, including an FDA OTC compliant arthritis pain relief product, APEAZ™, CIRCUMSerum™ an OTC product for increasing skin sensitivity to the penis, a line of prescription products in dermatitis as well as product candidates across each phase of development, such as its VAP-1 program for psoriasis and dermatitis. For more information, go to: www.innovuspharma.com.
CONTACT: Innovus Pharma Contact: Kevin Holmes Chesapeake Group email@example.com T: 410-825-3930